Minnesota FOIA #P010262904

Minnesota Regenerative Medicine Partnership – Preventing senescence in CART cells to improve therapeutic efficacy

This purchase order, issued on May 3, 2024, by the Twin Cities government agency, awards Mayo Clinic in Minneapolis, Minnesota, a contract valued at $200,000 for research on preventing senescence in CART cells to improve therapeutic efficacy as part of the Minnesota Regenerative Medicine Partnership. The order involves a single lot of research services, with Mayo Clinic identified as the vendor. The procurement is categorized under a contract for medical research services. The award is a single-transaction order with no specified multi-year period. The primary NAICS code relevant to this research activity is 541714 (Research and Development in Biotechnology). The award is located in Minneapolis, Hennepin County, Minnesota, USA. The contact details for the procurement are not specified. Likely competitors for similar awards include companies involved in biomedical research and biotechnology, such as Johns Hopkins University, Stanford University, and other research institutions or biotech firms involved in regenerative medicine.

Description

Minnesota Regenerative Medicine Partnership – Preventing senescence in CART cells to improve therapeutic efficacy